Emergent Biodefense
UnclaimedPharmaceutical Preparation ManufacturingLansing, MI
Founded
1998
Primary NAICS
325412
CAGE code
1H0B6
Federal awards
$93.8M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Medicinal and Botanical ManufacturingIn-Vitro Diagnostic Substance ManufacturingResearch and Development in Biotechnology (except Nanobiotechnology)
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Defense | $21,534,000 | 4 |
| 2026 | Department of Health and Human Services | $2,825 | 1 |
| 2025 | Department of Defense | $20,802,000 | 4 |
| 2024 | Department of Defense | $20,999,810 | 5 |
| 2023 | Department of Health and Human Services | -$10,454 | 1 |
| 2022 | Department of Health and Human Services | $30,518,394 | 7 |